Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Reexamination Certificate
2011-05-03
2011-05-03
Ware, Deborah K. (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
C424S282100, C424S408000, C435S177000, C435S178000, C435S252900, C435S822000
Reexamination Certificate
active
07935334
ABSTRACT:
An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specificallyPediococcus acidilacticiandSaccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected withElimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
REFERENCES:
patent: 4804542 (1989-02-01), Fischer et al.
patent: 5501857 (1996-03-01), Zimmer
patent: 5840318 (1998-11-01), Marshall et al.
patent: 5968569 (1999-10-01), Cavadini et al.
patent: 6500463 (2002-12-01), van Lengerich
patent: 6551633 (2003-04-01), Couzy et al.
patent: 6780447 (2004-08-01), Raczek
patent: 6827957 (2004-12-01), Paluch et al.
patent: 6835397 (2004-12-01), Lee et al.
patent: 7067150 (2006-06-01), Farber et al.
patent: 2003/0049240 (2003-03-01), Ballevre et al.
patent: 2003/0109025 (2003-06-01), Durand et al.
patent: 2003/0147858 (2003-08-01), Renaud et al.
patent: 2003/0165472 (2003-09-01), McGrath et al.
patent: 2004/0126356 (2004-07-01), Pang et al.
patent: 2004/0197352 (2004-10-01), Ranganathan
patent: 2006/0008511 (2006-01-01), Lin
Walker, Richard and Buckley, Merry. Probiotic Microbes the scientific Basis. American Acedemy of Microbiology symposium, Baltimore, Maryland, Nov. 5-7, 2005.
Tuomola, Elina et al., quality assurance criteria for probiotic bacteria. American Journal Clinical Nutrition 2001; 73(suppl):393S -8S.
Talwalkar, Akshat et al. The role of oxygen in the viability of probiotic bacteria with reference toL. acidophilusandBifidobacteriumspp. Current Issues Interest Microbiology, (2004) 5:1-8.
Perdigon, Gabriela et al. Lactic acid bacteria and their effect on the immunesystem. Current Issues Interest Microbiobiology. (2001) 2(1): 27-42.
Lillehoj, H.S. et al. Recent progress on the cytokine regulation of intestinal immune responses to Eimeria. Ancillary Scientists Symposium, Poultry Science Assoc. 2004 Poultry Science 83:611-623.
Isolauri, E. Probiotics for infectious diarrhoea. Gut 2003:52:436-437.
Dalloul, R.A. et al. Immunopotentiating effect of a fraxinea-derived lectin on chickne immunity and resistance to coccidiosis. 2006 Poultry Science 85:44 6-451.
Fuller, R. Probiotics in man and animals. Journal of Applied Bacteriology 1989, 66, 365-378.
Imagilin Technologies, LLC
Ware Deborah K.
LandOfFree
Probiotics as alternative medicines against infectious diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Probiotics as alternative medicines against infectious diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Probiotics as alternative medicines against infectious diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2633080